Methods Between January 1, 2000 and March 10, 2012, a total of 930 consecutive patients
who had been treated with amiodarone for arrhythmia were reviewed retrospectively. An …

Amiodarone is commonly used for a variety of arrhythmias and, in some parts of the world, is
the only available antiarrhythmic drug (AAD). Yet, amiodarone is known to have a wide …

Objectives. We sought to assess the odds of experiencing adverse effects with low dose
amiodarone therapy compared with placebo. Background. An estimate of the likelihood of …

Amiodarone has been associated with adverse events that may restrict its use. We
performed a meta-analysis of placebo-controlled trials to assess the relative risk of adverse …

Amiodarone, first used in Europe for the treatment of angina pectoris in the 1960s, began to
be widely utilized as an antiarrhythmic agent in the 1970s. Currently, it is one of the most …

Adverse effects will occur in 15% to 50% of patients from the first year of treatment with
amiodarone through prolonged treatment with it, and up to 5% of them will experience …

Amiodarone is commonly used to treat supraventricular and ventricular arrhythmias in
various inpatient and outpatient settings. Over-and under-use of amiodarone is common …

Objectives. To review the rationale and development of a multidisciplinary amiodarone
clinic, and document the clinical outcomes resulting from its implementation. Methods. A …

The dataset presented here provides a detailed description of the adverse events of
amiodarone versus placebo using data from 43 randomized controlled trials. Two authors …

Introduction Amiodarone is associated with significant long‐lasting adverse drug reactions
(ADR s). Guidelines recommend laboratory monitoring during long‐term use. However, data …